147 related articles for article (PubMed ID: 3195602)
1. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.
Deftos LJ; Linnoila RI; Carney DN; Burton DW; Leong SS; O'Connor DT; Murray SS; Gazdar AF
Cancer; 1988 Jul; 62(1):92-7. PubMed ID: 2838150
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid.
Schmid KW; Fischer-Colbrie R; Hagn C; Jasani B; Williams ED; Winkler H
Am J Surg Pathol; 1987 Jul; 11(7):551-6. PubMed ID: 3300386
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin and chromogranin A localization in medullary carcinoma of the thyroid by immunoelectron microscopy.
Silver MM; Hearn SA; Lines LD; Troster M
J Histochem Cytochem; 1988 Aug; 36(8):1031-6. PubMed ID: 3392392
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells.
Deftos LJ; Gazdar AF; Hogue-Angeletti R; Mullen PS; Burton DW
Bone Miner; 1990 Jun; 9(3):169-78. PubMed ID: 2163712
[TBL] [Abstract][Full Text] [Related]
6. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical, biochemical and immunoelectron microscopic analysis of antigenic proteins on neuroendocrine cell tumors using monoclonal antibody HISL-19.
Shimizu K; Namimatsu S; Kitagawa W; Akasu H; Takatsu K; Sugisaki Y; Tanaka S
J Nippon Med Sch; 2002 Aug; 69(4):365-72. PubMed ID: 12187369
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma.
Harach HR; Wilander E; Grimelius L; Bergholm U; Westermark P; Falkmer S
Pathol Res Pract; 1992 Feb; 188(1-2):123-30. PubMed ID: 1594480
[TBL] [Abstract][Full Text] [Related]
9. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
Hanna FW; Ardill JE; Johnston CF; Cunningham RT; Curry WJ; Russell CF; Buchanan KD
J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985
[TBL] [Abstract][Full Text] [Related]
10. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical characterization of a novel secretory protein (defined by monoclonal antibody HISL-19) of peptide hormone producing cells which is distinct from chromogranin A, B, and C.
Krisch K; Horvat G; Krisch I; Wengler G; Alibeik H; Neuhold N; Ulrich W; Braun O; Hochmeister M
Lab Invest; 1988 Apr; 58(4):411-20. PubMed ID: 2833657
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A as tumor marker in medullary thyroid carcinoma.
Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
[TBL] [Abstract][Full Text] [Related]
13. Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases.
Neuhold N; Ullrich R
Virchows Arch A Pathol Anat Histopathol; 1993; 423(2):85-9. PubMed ID: 7692664
[TBL] [Abstract][Full Text] [Related]
14. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
Franke WG; Pinkert J; Runge R; Bredow J; Wunderlich G; Koch R
Anticancer Res; 2000; 20(6D):5257-60. PubMed ID: 11326706
[TBL] [Abstract][Full Text] [Related]
16. Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.
Tomita T
Bosn J Basic Med Sci; 2021 Oct; 21(5):535-541. PubMed ID: 33485291
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
Seok JY; Kang M; De Peralta-Venturina M; Fan X
Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
[TBL] [Abstract][Full Text] [Related]
18. [Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research].
Schmid KW; Böcker W
Zentralbl Pathol; 1993 Jun; 139(2):115-29. PubMed ID: 8369268
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
Parmer M; Milan S; Torabi A
Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
[TBL] [Abstract][Full Text] [Related]
20. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors.
Lloyd RV; Cano M; Rosa P; Hille A; Huttner WB
Am J Pathol; 1988 Feb; 130(2):296-304. PubMed ID: 3341449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
